{"id":14258,"date":"2025-03-28T11:32:59","date_gmt":"2025-03-28T06:32:59","guid":{"rendered":"https:\/\/invest-in-uzbekistan.org\/?p=14258"},"modified":"2025-03-28T11:32:59","modified_gmt":"2025-03-28T06:32:59","slug":"malazijskaya-kompaniya-zainteresovana-v-realizatsii-proektov-v-farmatsevticheskoj-otrasli-uzbekistana","status":"publish","type":"post","link":"https:\/\/invest-in-uzbekistan.org\/uz\/novosti-uzbekistana\/malazijskaya-kompaniya-zainteresovana-v-realizatsii-proektov-v-farmatsevticheskoj-otrasli-uzbekistana\/","title":{"rendered":"Malayziya kompaniyasi O&#8217;zbekiston farmatsevtika sanoatida loyihalarni amalga oshirishdan manfaatdor"},"content":{"rendered":"<strong>O\u2018zbekiston elchisi Karomiddin Gadoyev \u201cParmaniaga Berhad\u201d kompaniyasi boshqaruvchi direktori Zulkifli Jafar bilan uchrashdi, deb <a href=\"https:\/\/dunyo.info\/ru\/ekonomicheskaya-diplomatiya\/malaziyskaya-kompaniya-zainteresovana-v-realizacii-proektov-v-farmacevticheskoy-otrasli-uzbekistana\">xabar bermoqda<\/a> \u201cDunyo\u201d axborot agentligi muxbiri.<\/strong><\/p>\n<p><a href=\"http:\/\/invest-in-uzbekistan.org\/wp-content\/uploads\/1743127910433_png.webp\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-14259\" src=\"http:\/\/invest-in-uzbekistan.org\/wp-content\/uploads\/1743127910433_png.webp\" alt=\"\" width=\"939\" height=\"489\" srcset=\"https:\/\/invest-in-uzbekistan.org\/wp-content\/uploads\/1743127910433_png.webp 939w, https:\/\/invest-in-uzbekistan.org\/wp-content\/uploads\/1743127910433_png-300x156.webp 300w, https:\/\/invest-in-uzbekistan.org\/wp-content\/uploads\/1743127910433_png-768x400.webp 768w, https:\/\/invest-in-uzbekistan.org\/wp-content\/uploads\/1743127910433_png-254x132.webp 254w\" sizes=\"auto, (max-width: 939px) 100vw, 939px\" \/><\/a><\/p>\n<p>Uchrashuvda O\u2018zbekistonda farmatsevtika ishlab chiqarish sohasidagi hamkorlik istiqbollari muhokama qilindi.<\/p>\n<p>Suhbat chog\u2018ida Zulkifli Jafar \u2018\u2018Pharmaniaga Berhad\u2019\u2019 kompaniyasi Malayziyada qandli diabet bilan og\u2018rigan bemorlar uchun halol standartlar bo\u2018yicha insulin ishlab chiqaradigan birinchi kompaniyalardan biri ekanligini aytdi. Ushbu insulin Malayziya hukumatining buyrug&#8217;i bilan davlat sog\u2018liqni saqlash muassasalariga etkazib beriladi. Shuningdek, kompaniya tomonidan mamlakatimizda qandli diabetga chalinganlar o\u2018rtasida insulin preparatlarini bepul tarqatish tizimi joriy etilganini ta\u2019kidladi.<\/p>\n<p>Bundan tashqari, \u2018\u2018Pharmaniaga Berhad\u2019\u2019 O\u2018zbekiston farmatsevtika sanoatini rivojlantirish agentligi bilan hamkorlik doirasida mamlakatimizda bir qator dori vositalarini qo\u2018shma ishlab chiqarishni tashkil etish istiqbollari ko\u2018rib chiqilayotganini alohida ta\u2019kidladi.<\/p>\n<p>Malayziya tomoni O\u2018zbekiston kompaniyalari bilan hamkorlikda \u201cTashkent Pharma Park\u201d farmatsevtika klasteri negizida halol insulin ishlab chiqarishni tashkil etishdan manfaatdor ekanligini bildirdi. Ta\u2019kidlanishicha, kompaniya birinchi bosqichda O\u2018zbekistondagi farmatsevtika korxonalarining mavjud quvvatlarida halol standartlari asosida ishlab chiqarishni tashkil etish uchun zarur texnologiyalarni Malayziyadan olib kelishga tayyor. Keyingi bosqichlarda ushbu biznesni rivojlantirishga sarmoya kiritish rejalashtirilgan.<\/p>\n<p>1994-yilda tashkil etilgan \u2018\u2018Pharmaniaga Berhad\u2019\u2019 kompaniyasi Malayziyada to\u2018rtta farmatsevtika ishlab chiqarish zavodiga, tadqiqot markaziga, logistika kompaniyasiga, tibbiy mahsulotlar va xizmatlar yetkazib berish, tibbiy mahsulotlarni sotish va sotish bilan shug&#8217;ullanuvchi korxonalarga ega. Bundan tashqari, kompaniya Indoneziyada uchta zavodni boshqaradi va 3400 dan ortiq kishi ishlaydi.","protected":false},"excerpt":{"rendered":"<p>O\u2018zbekiston elchisi Karomiddin Gadoyev \u201cParmaniaga Berhad\u201d kompaniyasi boshqaruvchi direktori Zulkifli Jafar bilan uchrashdi, deb xabar bermoqda \u201cDunyo\u201d axborot agentligi muxbiri. Uchrashuvda O\u2018zbekistonda farmatsevtika ishlab chiqarish sohasidagi hamkorlik istiqbollari muhokama qilindi&#8230;.<\/p>\n","protected":false},"author":1,"featured_media":14259,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-14258","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-novosti-uzbekistana"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/posts\/14258","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/comments?post=14258"}],"version-history":[{"count":1,"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/posts\/14258\/revisions"}],"predecessor-version":[{"id":14260,"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/posts\/14258\/revisions\/14260"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/media\/14259"}],"wp:attachment":[{"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/media?parent=14258"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/categories?post=14258"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invest-in-uzbekistan.org\/uz\/wp-json\/wp\/v2\/tags?post=14258"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}